Latest Regulatory News

Queensland Brine Solutions has locked in a strategic 10-hectare site to develop its Queensland Brine Management Complex, aiming to transform waste brine from the coal seam gas industry into valuable green chemicals.

Swift Networks has expanded its partnership with Uniting NSW to 25 aged care sites and introduced Swift TV at a major industry conference, positioning itself at the forefront of aged care technology innovation.

Talga Group and SQM have mutually terminated their joint venture for the Aero Project in Sweden due to regulatory delays, with Talga now exploring new partnership opportunities to advance the critical minerals project.

Lake Resources N.L. has released a replacement prospectus for its bonus loyalty options offer, adjusting key terms and updating its capital structure ahead of the 17 October record date. The offer aims to reward shareholders while potentially raising capital for its Kachi lithium project.

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

PainChek Limited has confirmed FDA De Novo classification for its PainChek Adult App, promptly disclosing the material regulatory milestone to the ASX and signalling a significant step towards US market entry.

Structural Monitoring Systems Plc faces a high-stakes legal battle as CEO Ross Love and Turton House Group initiate Federal Court proceedings alleging adverse action and whistleblower victimisation.

Strike Energy Limited has addressed ASX concerns over a delayed filing of a director’s interest notice, attributing the lapse to administrative oversight while affirming confidence in its compliance processes.

Health Canada has requested additional information, extending its review of CLINUVEL’s SCENESSE® for erythropoietic protoporphyria (EPP) into 2026. Meanwhile, Canadian patients continue to access the treatment via a Special Access Program.

Aspen Group has upgraded its FY26 pre-tax earnings guidance by 6%, driven by strong rental income growth and development profits amid Australia's acute housing shortage. The company also announces a strategic acquisition of a new Sydney headquarters.

Ark Mines has secured Environmental Authority approval for its Sandy Mitchell Rare Earths project in Queensland, marking a crucial step towards obtaining its Mining Licence. The company has also completed a major drilling program, setting the stage for an upcoming Pre-Feasibility Study.